AR225010A1 - Procedimiento para la obtencion de nuevos compuestos de imidazolina - Google Patents

Procedimiento para la obtencion de nuevos compuestos de imidazolina

Info

Publication number
AR225010A1
AR225010A1 AR275744A AR27574479A AR225010A1 AR 225010 A1 AR225010 A1 AR 225010A1 AR 275744 A AR275744 A AR 275744A AR 27574479 A AR27574479 A AR 27574479A AR 225010 A1 AR225010 A1 AR 225010A1
Authority
AR
Argentina
Prior art keywords
procedure
obtaining
imidazoline compounds
new imidazoline
new
Prior art date
Application number
AR275744A
Other languages
English (en)
Spanish (es)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Application granted granted Critical
Publication of AR225010A1 publication Critical patent/AR225010A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AR275744A 1978-03-08 1979-03-18 Procedimiento para la obtencion de nuevos compuestos de imidazolina AR225010A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH251978 1978-03-08

Publications (1)

Publication Number Publication Date
AR225010A1 true AR225010A1 (es) 1982-02-15

Family

ID=4235609

Family Applications (2)

Application Number Title Priority Date Filing Date
AR275744A AR225010A1 (es) 1978-03-08 1979-03-18 Procedimiento para la obtencion de nuevos compuestos de imidazolina
AR281806A AR227286A1 (es) 1978-03-08 1980-07-17 Procedimiento para la elaboracion de nuevos compuestos de 1-(2-imidazolidin-1-ilo-alquil)-3-fenilurea o tiourea

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR281806A AR227286A1 (es) 1978-03-08 1980-07-17 Procedimiento para la elaboracion de nuevos compuestos de 1-(2-imidazolidin-1-ilo-alquil)-3-fenilurea o tiourea

Country Status (28)

Country Link
US (2) US4292429A (fr)
EP (1) EP0004561B1 (fr)
JP (1) JPS54125668A (fr)
KR (2) KR820002098B1 (fr)
AR (2) AR225010A1 (fr)
AT (1) AT364375B (fr)
AU (1) AU531006B2 (fr)
CS (1) CS244656B2 (fr)
CY (1) CY1304A (fr)
DD (1) DD142336A5 (fr)
DE (1) DE2961198D1 (fr)
DK (1) DK95279A (fr)
ES (1) ES478342A1 (fr)
FI (1) FI70708C (fr)
GB (1) GB2016011B (fr)
GR (1) GR71998B (fr)
HK (1) HK80185A (fr)
HU (1) HU182940B (fr)
IL (1) IL56797A (fr)
MY (1) MY8700199A (fr)
NO (1) NO152606C (fr)
NZ (1) NZ189841A (fr)
OA (1) OA06201A (fr)
PH (1) PH16207A (fr)
PL (2) PL116762B1 (fr)
PT (1) PT69314A (fr)
SU (2) SU845779A3 (fr)
ZA (1) ZA791062B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338453A (en) 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use
DE3213509A1 (de) * 1982-04-10 1983-10-20 Basf Ag, 6700 Ludwigshafen N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
AU5234886A (en) * 1984-12-12 1986-07-01 MTD-Produkter I Smaland A.B. Method of preparing a hospital room or the like
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds
JP2008540362A (ja) * 2005-05-03 2008-11-20 ファルマ、マール、ソシエダード、アノニマ 抗腫瘍性テトラヒドロピリミジン
FR2901273B1 (fr) * 2006-05-19 2010-12-24 Anaconda Pharma Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
AU2009294225B2 (en) 2008-09-17 2013-07-18 William Kingston Tideway anchor system
WO2011108724A1 (fr) * 2010-03-04 2011-09-09 味の素株式会社 Agent prophylactique ou thérapeutique pour le diabète ou l'obésité
CA2791174C (fr) * 2010-03-04 2015-11-17 Ajinomoto Co., Inc. Derive d'alkylamine
CN102924380B (zh) * 2012-11-13 2014-12-31 齐鲁动物保健品有限公司 一种咪唑苯脲的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH234990A (de) * 1938-05-11 1944-10-31 Chem Ind Basel Verfahren zur Darstellung eines neuen therapeutisch wirksamen Amidins.
GB813525A (en) * 1956-07-09 1959-05-21 Socony Mobil Oil Co Inc Fuel oil composition
GB1082964A (en) * 1963-06-25 1967-09-13 Wellcome Found New substituted imidazolines and their preparation and use
US3455940A (en) * 1965-12-07 1969-07-15 Herbert C Stecker Certain halo and dihalo n-substituted salicylamides
GB1174349A (en) * 1966-08-25 1969-12-17 Boehringer Sohn Ingelheim Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
US3846071A (en) * 1969-02-12 1974-11-05 Petrolite Corp Process of inhibiting corrosion by treatment with phosphate-cyclic amidine salts
NL7415845A (nl) * 1973-12-26 1975-06-30 Upjohn Co Werkwijze voor het bevorderen van de productie van endogene prostaglandinen door zoogdieren, alsmede werkwijze ter bereiding van daarbij te gebruiken preparaten.
US4088766A (en) * 1975-06-25 1978-05-09 The Upjohn Company Urea containing compositions and methods
US4233451A (en) * 1976-05-20 1980-11-11 The Procter & Gamble Company Process for making imidazolinium salts
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use

Also Published As

Publication number Publication date
EP0004561B1 (fr) 1981-11-04
KR830000884B1 (ko) 1983-04-26
HK80185A (en) 1985-10-25
ES478342A1 (es) 1979-05-16
CY1304A (en) 1985-12-06
PH16207A (en) 1983-08-05
PL116762B1 (en) 1981-06-30
HU182940B (en) 1984-03-28
AU4490079A (en) 1979-09-13
US4420619A (en) 1983-12-13
OA06201A (fr) 1981-06-30
NO152606C (no) 1985-10-23
AU531006B2 (en) 1983-08-04
GR71998B (fr) 1983-08-26
NO790765L (no) 1979-09-11
SU923367A3 (ru) 1982-04-23
CS244656B2 (en) 1986-08-14
PL123150B1 (en) 1982-09-30
GB2016011A (en) 1979-09-19
PL213924A1 (fr) 1980-02-25
EP0004561A2 (fr) 1979-10-17
FI70708B (fi) 1986-06-26
JPS629109B2 (fr) 1987-02-26
AT364375B (de) 1981-10-12
DE2961198D1 (en) 1982-01-14
ZA791062B (en) 1980-03-26
KR820002098B1 (ko) 1982-11-05
PT69314A (de) 1979-04-01
GB2016011B (en) 1982-08-25
IL56797A (en) 1982-09-30
AR227286A1 (es) 1982-10-15
JPS54125668A (en) 1979-09-29
ATA171079A (de) 1981-03-15
FI790740A (fi) 1979-09-09
NZ189841A (en) 1982-03-09
EP0004561A3 (en) 1979-11-14
DK95279A (da) 1979-09-09
MY8700199A (en) 1987-12-31
US4292429A (en) 1981-09-29
NO152606B (no) 1985-07-15
FI70708C (fi) 1986-10-06
SU845779A3 (ru) 1981-07-07
DD142336A5 (de) 1980-06-18

Similar Documents

Publication Publication Date Title
ES481909A0 (es) Procedimiento para la preparacion de nuevas aril-3 eter-5 o-xazolidinonas-2
MX5631E (es) Procedimiento para la preparacion de acil-anilinas
MX5793E (es) Procedimiento para la preparacion de 4-amino-5-alquilsulfonil-orto-anisamidas
MX5578E (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
ES528142A0 (es) Procedimiento para la obtencion de compuestos de hexapiranosa
MX7633E (es) Procedimiento para la preparacion de compuestos de difenileter
ES528579A0 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
AR227379A1 (es) Procedimiento para la preparacion de 1-aril-2-imidazolil vinileteres
MX5509E (es) Procedimiento para la preparacion de n-halogenoacetil-fenilaminocarboniloximas
AR227527A1 (es) Procedimiento para la elaboracion de nuevos compuestos n-oxaciclilalquil-piperidil-diazoicos
AR225010A1 (es) Procedimiento para la obtencion de nuevos compuestos de imidazolina
MX5898E (es) Procedimiento para la preparacion de 2-amino-4-pirimidonas
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
ES485567A0 (es) Procedimiento para la preparacion de azolilcetales
ES490987A0 (es) Procedimiento para la obtencion de nuevos aldehido-eteres alifaticos
ES528267A0 (es) Procedimiento para la obtencion de nuevos compuestos de aralquiltriazol
ES484342A0 (es) Procedimiento para la preparacion de propenilensulfona
MX149694A (es) Procedimiento para la preparacion de trialcoxisilanos de fenoxialquilo
ES488835A0 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
MX6232E (es) Procedimiento para la preparacion de auronas substituidas
ES500267A0 (es) Procedimiento para la obtencion de compuestos de isotiazoli-lo
MX5605E (es) Procedimiento mejorado para la preparacion de 2-isopropilaminopirimidina
ES493956A0 (es) Procedimiento para la obtencion de compuestos de antraquino-na-azometina
ES490198A0 (es) Procedimiento mejorado para la preparacion de sulfonilureas
ES487167A0 (es) Procedimiento para la obtencion de 2-fenilamino-imidazolinas-(2)sustituidos